Progyny, Inc. financial data

Symbol
PGNY on Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
Location
1359 Broadway, 2 Nd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Auxogyn, Inc. (to 3/19/2015), Auxogyn Inc (to 9/16/2013)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 297 % +4.85%
Debt-to-equity 44.3 % -2.81%
Return On Equity 11.4 % -2.41%
Return On Assets 7.87 % -1.5%
Operating Margin 5.71 % +92.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.2M shares -11.1%
Common Stock, Shares, Outstanding 88.3M shares -7.75%
Entity Public Float 3.3B USD +43.5%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 90.1M shares -5.69%
Weighted Average Number of Shares Outstanding, Diluted 93.8M shares -7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.09B USD +38.3%
Selling and Marketing Expense 63.2M USD +9.88%
General and Administrative Expense 118M USD +0.82%
Operating Income (Loss) 65.5M USD +26.7%
Nonoperating Income (Expense) 16.3M USD +137%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 81.8M USD +39.7%
Income Tax Expense (Benefit) 24.5M USD +272%
Net Income (Loss) Attributable to Parent 57.3M USD +10.2%
Earnings Per Share, Basic 0.62 USD/shares +10.7%
Earnings Per Share, Diluted 0.58 USD/shares +11.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91.5M USD -42.1%
Accounts Receivable, after Allowance for Credit Loss, Current 281M USD +4.45%
Assets, Current 546M USD -10.6%
Deferred Income Tax Assets, Net 63.8M USD -11.5%
Property, Plant and Equipment, Net 11.9M USD +22.8%
Operating Lease, Right-of-Use Asset 17.4M USD -3.27%
Goodwill 15.8M USD +33%
Other Assets, Noncurrent 3.3M USD -8%
Assets 660M USD -9.16%
Accounts Payable, Current 130M USD -1.19%
Employee-related Liabilities, Current 11.9M USD +54%
Liabilities, Current 208M USD +7.78%
Operating Lease, Liability, Noncurrent 16.6M USD -6.07%
Liabilities 225M USD +6.62%
Accumulated Other Comprehensive Income (Loss), Net of Tax 330K USD -82.1%
Retained Earnings (Accumulated Deficit) 134M USD +74.9%
Stockholders' Equity Attributable to Parent 435M USD -15.6%
Liabilities and Equity 660M USD -9.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 25.7M USD +22.8%
Net Cash Provided by (Used in) Financing Activities -27.4M USD -1385%
Net Cash Provided by (Used in) Investing Activities 19.3M USD +19.9%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 97.5M shares +1.79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 17.7M USD -49.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 91.5M USD -42.1%
Deferred Tax Assets, Valuation Allowance 513K USD +129%
Deferred Tax Assets, Gross 80.3M USD -1%
Operating Lease, Liability 19.5M USD +0.04%
Payments to Acquire Property, Plant, and Equipment 850K USD -32.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 55.8M USD +3.99%
Lessee, Operating Lease, Liability, to be Paid 23.8M USD -3.06%
Property, Plant and Equipment, Gross 15.5M USD +35%
Operating Lease, Liability, Current 2.87M USD +60.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.01M USD +7.88%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.01M USD +33.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.34M USD -14.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.02M USD +8.06%
Deferred Tax Assets, Operating Loss Carryforwards 16.8M USD -59.1%
Unrecognized Tax Benefits 390K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.02M USD +8.24%
Operating Lease, Payments 300K USD 0%
Depreciation, Depletion and Amortization 716K USD +32.3%
Deferred Tax Assets, Net of Valuation Allowance 79.8M USD -1.36%
Share-based Payment Arrangement, Expense 126M USD +2.41%